Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment
Robert B. Kargbo
Abstract:Addressing the significant challenges of treating depression,
anxiety,
and substance abuse, this Patent Highlight explores the development
of innovative small-molecule heterocyclic compounds as Gq-biased agonists
of the 5-HT2A receptor. Unlike traditional treatments, these compounds
selectively activate 5-HT2A-mediated Gq signaling, excluding related
receptors like 5-HT2B and 5-HT2C. This selectivity suggests a more
targeted and efficient therapeutic approach. The discovery of these
compounds could herald a ne… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.